(R)-1-(4-methylnaphtalen-1-yl)but-3-en 1-ol | 1115246-82-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: (R)-1-(4-methylnaphtalen-1-yl)but-3-en 1-ol
• 英文别名: (R)-1-(4-methylnaphthalen-1-yl)-but-3-en-1-ol；(1R)-1-(4-methylnaphthalen-1-yl)but-3-en-1-ol
• CAS: 1115246-82-6
• 化学式: C₁₅H₁₆O
• 分子量: 212.291
• InChiKey: GAHWQFSKSDFGAI-OAHLLOKOSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  4-甲基-1-萘醛 、 烯丙基三甲氧基硅烷 在 silver fluoride 、 (±)-2,2 '-二(二-对甲苯基膦)-1,1 '-联萘 作用下， 以 甲醇 为溶剂， 反应 48.0h， 以88%的产率得到
  参考文献：
  名称：

  Antiproliferative activity of (R)-4′-methylklavuzon on hepatocellular carcinoma cells and EpCAM+/CD133+ cancer stem cells via SIRT1 and Exportin-1 (CRM1) inhibition

  摘要：

  Cytotoxic effects of (R)-4'-methylklavuzon were investigated on hepatocellular carcinoma cells (HuH-7 and HepG2) and HuH-7 EpCAM(+)/CD133(+) cancer stem cells. IC50 of (R)-4'-methylklavuzon was found as 1.25 mu M for HuH-7 parental cells while it was found as 2.50 mu M for HuH-7 EpCAM(+)/CD133(+) cancer stem cells. (R)-4'-methylklavuzon tended to show more efficient in vitro cytotoxicity with its lower IC50 values on hepatocellular carcinoma cell lines compared to its lead molecule, goniothalamin and FDA-approved drugs, sorafenib and regorafenib. Cell-based Sirtuin/HDAC enzyme activity measurements revealed that endogenous Sirtuin/HDAC enzymes were reduced by 40% compared to control. SIRT1 protein levels were upregulated indicating triggered DNA repair mechanism. p53 was overexpressed in HepG2 cells. (R)-4'methylklavuzon inhibited CRM1 protein providing increased retention of p53 and RIOK2 protein in the nucleus. HuH-7 parental and EpCAM(+)/CD133(+) cancer stem cell spheroids lost intact morphology. 3D HepG2 spheroid viabilities were decreased in a correlation with upregulation in p53 protein levels. (C) 2019 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2019.07.024

文献信息

• [EN] A NEW CLASS OF HIGHLY APOPTOTIC ANTI-CANCER AGENTS<br/>[FR] NOUVELLE CLASSE D'AGENTS ANTICANCÉREUX HAUTEMENT APOPTOTIQUES
  申请人：CAGIR ALI

  公开号：WO2011099947A1

  公开（公告）日：2011-08-18

  This invention relates to a list of apoptosis-inducers consisting of 6-bicycloaryl substituted 5,6-dihydro-2H-pyran-2-one derivatives. According to the present invention, the apoptosis-inducers trigger cell death by expression of a list of apoptotic genes, so they can be useful for the treatment of cancers, or other autoimmune diseases suffering from the lack of apoptosis such as viral infections, diabetes type I, or encephalomyelitis.

  这项发明涉及一种由6-双环芳基取代的5,6-二氢-2H-吡喁-2-酮衍生物组成的凋亡诱导剂列表。根据本发明，这些凋亡诱导剂通过表达一系列凋亡基因来触发细胞死亡，因此它们可以用于治疗癌症或其他由于凋亡缺乏而受影响的自身免疫疾病，如病毒感染、1型糖尿病或脑脊髓炎。
• 6-Bicycloaryl substituted (S)- and (R)-5,6-dihydro-2H-pyran-2-ones: Asymmetric synthesis, and anti-proliferative properties
  作者：Pınar Kasaplar、Özgür Yılmazer、Ali Çağır

  DOI：10.1016/j.bmc.2008.10.069

  日期：2009.1

  (R)-Goniothalamin, is a member of styryl lactones, possesses selective cytotoxicity against cancer cell lines. In this work, replacement of styryl substituent with 2-naphthyl and 3-quinoyl gave new analogues which may have less conformational changes compared to the lead compound. Anti-proliferative tests indicated that 2-naphthyl substituted (R)-5,6-dihydro-2H-pyran-2-one has slightly better cytotoxicity than (R)-goniothalamin. To clarify the effect of 2-naphthyl substituent additional aryl substituted (R)-5,6-dihydro-2H-pyran-2-ones have been synthesized enantioselectively and tested against PC-3 and MCF-7 cell lines. (C) 2008 Elsevier Ltd. All rights reserved.
• Antiproliferative activity of (R)-4′-methylklavuzon on hepatocellular carcinoma cells and EpCAM+/CD133+ cancer stem cells via SIRT1 and Exportin-1 (CRM1) inhibition
  作者：Murat Delman、Sanem Tercan Avcı、İsmail Akçok、Tuğçe Kanbur、Esra Erdal、Ali Çağır

  DOI：10.1016/j.ejmech.2019.07.024

  日期：2019.10

  Cytotoxic effects of (R)-4'-methylklavuzon were investigated on hepatocellular carcinoma cells (HuH-7 and HepG2) and HuH-7 EpCAM(+)/CD133(+) cancer stem cells. IC50 of (R)-4'-methylklavuzon was found as 1.25 mu M for HuH-7 parental cells while it was found as 2.50 mu M for HuH-7 EpCAM(+)/CD133(+) cancer stem cells. (R)-4'-methylklavuzon tended to show more efficient in vitro cytotoxicity with its lower IC50 values on hepatocellular carcinoma cell lines compared to its lead molecule, goniothalamin and FDA-approved drugs, sorafenib and regorafenib. Cell-based Sirtuin/HDAC enzyme activity measurements revealed that endogenous Sirtuin/HDAC enzymes were reduced by 40% compared to control. SIRT1 protein levels were upregulated indicating triggered DNA repair mechanism. p53 was overexpressed in HepG2 cells. (R)-4'methylklavuzon inhibited CRM1 protein providing increased retention of p53 and RIOK2 protein in the nucleus. HuH-7 parental and EpCAM(+)/CD133(+) cancer stem cell spheroids lost intact morphology. 3D HepG2 spheroid viabilities were decreased in a correlation with upregulation in p53 protein levels. (C) 2019 Elsevier Masson SAS. All rights reserved.